The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
Open accessAbstract
During organogenesis, immunosurveillance, and inflammation, chemokines selectively recruit leukocytes by activating seven-transmembrane-spanning receptors. It has been suggested that an important component of this process is the formation of a haptotactic gradient by immobilization of chemokines on cell surface glycosaminoglycans (GAGs). However, this hypothesis has not been experimentally demonstrated in vivo . In the present study we investigated the effect of mutations in the GAG binding sites of three chemokines, monocyte chemoattractant protein-1/CC chemokine ligand (CCL)2, macrophage-inflammatory protein-1β/CCL4, and RANTES/CCL5, on their ability to recruit cells in vivo . These mutant chemokines retain chemotactic activity in vitro , but they are unable to recruit cells when administered intraperitoneally. Additionally, monomeric variants, although fully active in vitro , are devoid of activity in vivo . These data demonstrate that both GAG binding and the ability to form higher-order oligomers are essential for the activity of particular chemokines in vivo , although they are not required for receptor activation in vitro . Thus, quaternary structure of chemokines and their interaction with GAGs may significantly contribute to the localization of leukocytes beyond migration patterns defined by chemokine receptor interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.881 · Cited by 806
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature Reviews Immunology · doi:10.1038/nri722 · Cited by 752
Self-citationTranscytosis and Surface Presentation of IL-8 by Venular Endothelial Cells
Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., & Rot, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80422-5 · Cited by 729
Self-citationGlycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines
Hoogewerf, A. J., Kuschert, G. S. V., Proudfoot, A. E. I., Borlat, F., Clark-Lewis, I., Power, C. A., & Wells, T. N. C. (1997) · Biochemistry · doi:10.1021/bi971125s · Cited by 510
Self-citationNeutrophil Activation by Monomeric Interleukin-8
Rajarathnam, K., Sykes, B. D., Kay, C. M., Dewald, B., Geiser, T., Baggiolini, M., & Clark-Lewis, I. (1994) · Science · doi:10.1126/science.8140420 · Cited by 356
Self-citationβ-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
Wagner, L., Yang, O. O., Garcia-Zepeda, E. A., Ge, Y., Kalams, S. A., Walker, B. D., Pasternack, M. S., & Luster, A. D. (1998) · Nature · doi:10.1038/36129 · Cited by 329
Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J.-L., Delepierre, M., Baleux, F., Lortat-Jacob, H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23916 · Cited by 323
The BBXB Motif of RANTES Is the Principal Site for Heparin Binding and Controls Receptor Selectivity
Proudfoot, A. E. I., Fritchley, S., Borlat, F., Shaw, J. P., Vilbois, F., Zwahlen, C., Trkola, A., Marchant, D., Clapham, P. R., & Wells, T. N. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010867200 · Cited by 248
Self-citationRot, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230150 · Cited by 214
Cited by
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
“In support of this model, monocyte recruitment is impaired by amino acid substitutions in CCL2 that prevent dimerization or association with glycosaminoglycan”
BackgroundThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Regulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Advancing biomaterials of human origin for tissue engineering
Chen, F.-M., & Liu, X. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.02.004 · Cited by 1,158
Monocyte-Mediated Defense Against Microbial Pathogens
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090326 · Cited by 1,123
The Chemokine System in Innate Immunity
Sokol, C. L., & Luster, A. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016303 · Cited by 862
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Chemokines: multiple levels of leukocyte migration control☆
Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 860
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Chemokine:Receptor Structure, Interactions, and Antagonism
Allen, S. J., Crown, S. E., & Handel, T. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090529 · Cited by 839
Self-citationThe role of CXC chemokines and their receptors in cancer
Vandercappellen, J., Van Damme, J., & Struyf, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.050 · Cited by 643
Pathophysiology of Myocardial Infarction
Frangogiannis, N. G. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c150006 · Cited by 618
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Gschwandtner, M., Derler, R., & Midwood, K. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02759 · Cited by 611
Cambier, S., Gouwy, M., & Proost, P. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00974-6 · Cited by 591
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 508
Self-citationThe role of heparan sulphate in inflammation
Parish, C. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1918 · Cited by 495
Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Panee, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.018 · Cited by 402
Palomino, D. C. T., & Marti, L. C. (2015) · Einstein (São Paulo) · doi:10.1590/s1679-45082015rb3438 · Cited by 389
Targeting CCL5 in inflammation
Marques, R. E., Guabiraba, R., Russo, R. C., & Teixeira, M. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.837886 · Cited by 384
Inflammation and fibrosis in murine models of heart failure
Bacmeister, L., Schwarzl, M., Warnke, S., Stoffers, B., Blankenberg, S., Westermann, D., & Lindner, D. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0722-5 · Cited by 382
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Veillard, N. R., Kwak, B., Pelli, G., Mulhaupt, F., James, R. W., Proudfoot, A. E. I., & Mach, F. (2004) · Circulation Research · doi:10.1161/01.res.0000109793.17591.4e · Cited by 377
Self-citationHeterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
Self-citationGram-positive anaerobic cocci – commensals and opportunistic pathogens
Murphy, E. C., & Frick, I.-M. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12005 · Cited by 352
Pruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J., Richmond, A., Graham, G. J., Segerer, S., Nibbs, R. J. B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1675 · Cited by 339
Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions
Sawant, K. V., Poluri, K. M., Dutta, A. K., Sepuru, K. M., Troshkina, A., Garofalo, R. P., & Rajarathnam, K. (2016) · Scientific Reports · doi:10.1038/srep33123 · Cited by 337
Metzemaekers, M., Vanheule, V., Janssens, R., Struyf, S., & Proost, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01970 · Cited by 328
How chemokines invite leukocytes to dance
Thelen, M., & Stein, J. V. (2008) · Nature Immunology · doi:10.1038/ni.f.207 · Cited by 324
Lekakis, J., Abraham, P., Balbarini, A., Blann, A., Boulanger, C. M., Cockcroft, J., Cosentino, F., Deanfield, J., Gallino, A., Ikonomidis, I., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711398179 · Cited by 315
CXCR3 ligands in disease and therapy
Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J., & Struyf, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 310
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Gervais, F., Paquette, J., Morissette, C., Krzywkowski, P., Yu, M., Azzi, M., Lacombe, D., Kong, X., Aman, A., Laurin, J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.015 · Cited by 307
Interconversion between two unrelated protein folds in the lymphotactin native state
Tuinstra, R. L., Peterson, F. C., Kutlesa, S., Elgin, E. S., Kron, M. A., & Volkman, B. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709518105 · Cited by 307
The chemokine receptor D6 limits the inflammatory response in vivo
Jamieson, T., Cook, D. N., Nibbs, R. J. B., Rot, A., Nixon, C., Mclean, P., Alcami, A., Lira, S. A., Wiekowski, M., & Graham, G. J. (2005) · Nature Immunology · doi:10.1038/ni1182 · Cited by 302
O'Hayre, M., Salanga, C. L., Handel, T. M., & Allen, S. J. (2008) · Biochemical Journal · doi:10.1042/bj20071493 · Cited by 297
Self-citationWhite, G. E., Iqbal, A. J., & Greaves, D. R. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005074 · Cited by 289
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Veldkamp, C. T., Seibert, C., Peterson, F. C., De la Cruz, N. B., Haugner, J. C., Basnet, H., Sakmar, T. P., & Volkman, B. F. (2008) · Science Signaling · doi:10.1126/scisignal.1160755 · Cited by 287
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
Bergin, D. A., Reeves, E. P., Meleady, P., Henry, M., McElvaney, O. J., Carroll, T. P., Condron, C., Chotirmall, S. H., Clynes, M., O’Neill, S. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41196 · Cited by 287
Mechanisms of Regulation of the Chemokine-Receptor Network
Stone, M., Hayward, J., Huang, C., E. Huma, Z., & Sanchez, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020342 · Cited by 275
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Tal, O., Lim, H. Y., Gurevich, I., Milo, I., Shipony, Z., Ng, L. G., Angeli, V., & Shakhar, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102392 · Cited by 269
Jia, T., Serbina, N. V., Brandl, K., Zhong, M. X., Leiner, I. M., Charo, I. F., & Pamer, E. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6846 · Cited by 256
The chemokine system – a major regulator of angiogenesis in health and disease
ROSENKILDE, M. M., & SCHWARTZ, T. W. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0808.x · Cited by 255
Acute Inflammation in Tissue Healing
Soliman, A. M., & Barreda, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010641 · Cited by 254
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073868 · Cited by 253
The blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
“Mutations that inhibit binding to heparin do not affect chemokine binding to cognate receptors yet diminishes their ability to induce cell migration in vivo [73–75].”
BackgroundMechanisms of leukocyte migration across the blood-retina barrier
Crane, I. J., & Liversidge, J. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0106-7 · Cited by 152
Chemokines in COPD: From Implication to Therapeutic Use
Henrot, P., Prevel, R., Berger, P., & Dupin, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112785 · Cited by 131
Control of Chemokine Gradients by the Retinal Pigment Epithelium
Shi, G., Maminishkis, A., Banzon, T., Jalickee, S., Li, R., Hammer, J., & Miller, S. S. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1816 · Cited by 102
Wegrowski, Y., Milard, A.-L., Kotlarz, G., Toulmonde, E., Maquart, F.-X., & Bernard, J. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03059.x · Cited by 70
Srinivasan, A., Sathiyanathan, P., Yin, L., Liu, T. M., Lam, A., Ravikumar, M., Smith, R. A. A., Loh, H. P., Zhang, Y., Ling, L., et al. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2021.11.009 · Cited by 44
The Matrisome, Inflammation, and Liver Disease
Dolin, C. E., & Arteel, G. E. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402516 · Cited by 38
Huang, M., Celniker, A. F., Chitsazi, R., Dyer, D. P., Jansma, A. L., Kufareva, I., Salanga, C. L., & Handel, T. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110736 · Cited by 1
Self-citation
Metadata
- Authors
- Proudfoot, A. E. I., Handel, T. M., Johnson, Z., Lau, E. K., LiWang, P., Clark-Lewis, I., Borlat, F., Wells, T. N. C., & Kosco-Vilbois, M. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-02-05
- Volume
- 100
- Issue
- 4
- Pages
- 1885-1890
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061814831
- Cited by
- 781
- References
- 23
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.